首页> Nature communications> Loss of CFHR5 function reduces the risk for age-related macular degeneration.

Loss of CFHR5 function reduces the risk for age-related macular degeneration.

导出 OA

翻译打印收藏纠错

第一作者： Mary Pat,Reeve

第一单位： Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.;Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.;Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

作者： Mary Pat,Reeve ^[1] ; Stephanie,Loomis ^[2] ; Eija,Nissilä ^[3] ; Thomas W,Soare ^[4] ; Tobias,Rausch ^[5] ; Zhili,Zheng ^[6] ; Pietro,Della Briotta Parolo ^[6] ; Daniel,Ben-Isvy ^[7] ; Elias,Aho ^[3] ; Emilia,Cesetti ^[8] ; Yoko,Okunuki ^[2] ; Helen,McLaughlin ^[2] ; Johanna,Mäkelä ^[9] ; FinnGen ^[1] ; Mitja,Kurki ^[10] ; Michael E,Talkowski ^[5] ; Jan O,Korbel ^[2] ; Kip,Connor ^[3] ; Seppo,Meri ^[11] ; Mark J,Daly ^[12] ; Heiko,Runz

作者单位： Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.;Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.;Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA. ^[1] Research and Development, Biogen Inc, Cambridge, MA, USA. ^[2] Department of Bacteriology and Immunology, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland. ^[3] insitro Inc., South San Francisco, CA, USA. ^[4] European Molecular Biological Laboratories (EMBL), Heidelberg, Germany. ^[5] Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.;Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA. ^[6] Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.;Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.;Division of Medical Sciences, Harvard Medical School, Boston, MA, USA. ^[7] Department of Bacteriology and Immunology, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.;Department of Biomedical Sciences, Humanitas University, Milan, Italy. ^[8] Finnish Biobank Cooperative (FinBB), Turku, Finland. ^[9] Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.;Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. ^[10] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. mjdaly@broadinstitute.org.;Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. mjdaly@broadinstitute.org.;Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA. mjdaly@broadinstitute.org. ^[11] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. heiko.runz@gmail.com.;Research and Development, Biogen Inc, Cambridge, MA, USA. heiko.runz@gmail.com.;insitro Inc., South San Francisco, CA, USA. heiko.runz@gmail.com.;European Molecular Biological Laboratories (EMBL), Heidelberg, Germany. heiko.runz@gmail.com. ^[12]